Showing results (21-30 of 685) with videos related to
Sort By:
Pageof 69
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 6, 1997
[Prostate cancer]J Shimazaki, S Isaka, K Akakura, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|February 26, 1998
Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: comparison with prostatic acid phosphatase and alkaline phosphataseS Akimoto, Y Furuya, K Akakura, et al.Hinyokika Kiyo. Acta Urologica Japonica|July 1, 1990
[Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer]S Akimoto, K Akakura, M Masai, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
Chemotherapy for endocrine-therapy-refractory prostate cancerS Akimoto, T Ohki, K Akakura, et al.Japanese Journal of Clinical Oncology|August 1, 1997
Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphataseS Akimoto, H Inomiya, K Akakura, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 1995
Disease progression in stage A prostate cancerM Amakasu, S Akimoto, K Akakura, et al.The Prostate|February 11, 1999
Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: comparison with the extent of disease (EOD) gradeS Akimoto, Y Furuya, K Akakura, et al.Hinyokika Kiyo. Acta Urologica Japonica|November 1, 1994
[Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer]S Akimoto, T Ohki, T Ichikawa, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|February 26, 1998
Influence of osteoarthritis on serum marker levels of bone formation and resorption in patients with benign prostatic hypertrophyS Akimoto, Y Furuya, K Akakura, et al.Endocrinologia Japonica|February 1, 1985
Binding of mibolerone to androgen receptor of benign hypertrophic human prostate. Comparison with R1881S Akimoto, H Fuse, R Sato, et al.Pageof 69